Inspirata AI Delivers Record Q2 with Five Major Academic Cancer Centers Selecting Its Native AI Platform

PartnershippositivePositive

AI Analysis

Summary

Inspirata AI announced record Q2 results highlighted by five academic cancer centers selecting its AI & ONCO platform as their enterprise cancer registry solution. The selection represents multi-year customer agreements for the platform.

Outcome Details

Five leading academic cancer centers selected Inspirata AI & ONCO as their enterprise cancer registry solution

Importance:5/10

Sentiment:

0.70

partnershipscancerAI_platformenterprise_softwareQ2_results

Read the original article

Published by PR Newswire Clinical Trials on August 18, 2026 12:00 PM

Read Original